As a global leader in the pharmaceutical industry, Farmson Basic Drugs has set the benchmark for high-quality Active Pharmaceutical Ingredients (APIs), particularly Paracetamol. With a steadfast commitment to innovation, efficiency, and sustainability, Farmson has taken a significant leap forward by expanding its capabilities to include Paracetamol Directly Compressible (DC) granules.

This forward integration marks a major milestone, offering end-to-end solutions—from API production to ready-to-compress DC granules—ensuring unmatched consistency and quality in tablet formulation.

State-of-the-Art Manufacturing: Precision at Every Step

Farmson’s cutting-edge manufacturing facilities are equipped with state-of-the-art technology, ensuring precision, efficiency, and compliance with the highest industry standards.

Advanced Granulation Technology – Our Paracetamol DC plant features fully integrated Granulation lines from GLATT, a global leader in advanced pharmaceutical processing solutions. This investment guarantees superior compressibility and flowability, making our DC granules the preferred choice for tablet manufacturers worldwide.

Seamless API-to-Tablet Transition – By producing DC granules in-house, Farmson ensures a smooth and controlled transition from API to final formulation. This not only enhances product consistency but also eliminates dependency on third-party granulation, giving customers a reliable and high-quality end product.

Commitment to Quality, Compliance & Sustainability

At Farmson, quality is non-negotiable. We adhere to the most stringent global regulatory standards, including WHO-GMP, ensuring that every batch of Paracetamol DC granules meets the highest levels of safety and efficacy.

Sustainability at the Core – Farmson prioritizes eco-friendly manufacturing, implementing processes that minimize environmental impact and optimize resource utilization. From energy-efficient production to responsible waste management, we are committed to reducing our carbon footprint while maintaining industry leadership.

Superior Granule Characteristics – Our Paracetamol DC granules are engineered for:
✔ High flowability – Ensuring uniform tablet weight and content.
✔ Excellent compressibility – Reducing formulation challenges for tablet manufacturers.
✔ Minimal dust generation – Enhancing safety and efficiency in production.

Market Leadership: Scaling New Heights

With an annual Paracetamol production capacity of 52,000 MTPA (Metric Tons Per Annum), Farmson stands as one of the largest and most trusted API manufacturers globally. Our strategic expansion into DC granules strengthens our position, allowing us to cater to pharmaceutical companies seeking superior-quality excipients for direct compression formulations.

As we continue to innovate and expand our portfolio, Farmson remains committed to delivering cutting-edge solutions that empower pharmaceutical manufacturers worldwide.

The Future of Paracetamol Manufacturing Begins Here

With unparalleled expertise, forward integration, and a commitment to sustainability, Farmson Basic Drugs is redefining Paracetamol DC granule manufacturing. Our investment in advanced technology, seamless production processes, and global quality standards ensures that we continue to lead the industry with excellence and reliability.

For more information on our Paracetamol DC granules and partnership opportunities, reach out to us at info@farmson.com